galactosamine has been researched along with isoliquiritigenin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bawankule, DU; Bhakuni, RS; Gaur, R; Kumar, S; Pal, A; Shanker, K; Trivedi, P | 1 |
Huang, K; Kong, L; Liu, K; Meng, Q; Sun, H; Wang, C; Wang, L; Wang, S; Wang, X; Wu, J | 1 |
2 other study(ies) available for galactosamine and isoliquiritigenin
Article | Year |
---|---|
Liquiritigenin derivatives and their hepatotoprotective activity.
Topics: Animals; Cells, Cultured; Chalcones; Cytoprotection; Flavanones; Flavonoids; Galactosamine; Glycyrrhiza; Hepatocytes; Male; Rats; Rats, Wistar | 2010 |
Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cells, Cultured; Chalcones; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Inflammasomes; Inflammation Mediators; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction | 2021 |